ESTRO 36 Programme book and exhibition guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

ELECTRONIC POSTERS

> Non-small cell lung cancer invading the vertebra: what is the optimal strategy for radiation? S. Appel (Israel), J. Goldstein, Z. Symon, Y. Lawrence, M. Ben aiun, N. Honig, T. Rabin > Prognostic values of tumour markers in lung cancer patients treated with definitive chemoradiotherapy J.H. Chung (Republic of Korea), J.S. Kim > Concomitant radiotherapy and TKI in EGFR mutant or ALK positive stage IV non-small cell lung cancer P. Borghetti (Italy), M. Bonù, E. Roca, E. Salah, A. Baiguini, S. Pedretti, M. Maddalo, M. Buglione, S. Magrini > Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy R. Bütof (Germany), C. Gumina, C. Valentini, A. Sommerer, S. Appold, D. Zips, S. Löck, M. Baumann, E.G.C. Troost > Adherence to lung cancer guidelines and its impact on survival I. Linares (Spain), M. Sánchez, J. Pérez-Alija, E. Molina, Y. Chang-Chan, R. Guerrero, J. Expósito > Beclin-1 expression of circulating tumor cells in non-small cell lung cancer patients. C. Prieto Prieto (Spain), D. De Miguel > Comparing concurrent versus sequential chemoradiotherapy in locally advanced NSCLC G. Wei (China), G. Xiaobin, G. Xian-Shu, M. Mingwei, C. Ming, P. Chuan > Therapeutic effects of accelerated hyperfractionation and conventional fractionation CRT on NSCLC T. Mitsuyoshi (Japan), Y. Matsuo, T. Shintani, Y. Iizuka, W.A. Mampuya, H. Nagai, H. Ozasa, Y.H. Kim, T.F. Chen-Yoshikawa, M. Sonobe, N. Nakajima, A. Yoshizawa, T. Mizowaki, H. Date, M. Hiraoka > Atlas-based segmentation reduces inter-observer variation and delineation time for OAR in NSCLC W. Van Elmpt (The Netherlands), J. Van der Stoep, J. Van Soest, T. Lustberg, M. Gooding, A. Dekker

EP-1217

EP-1218

EP-1219

EP-1220

EP-1221

EP-1222

EP-1223

EP-1224

EP-1225

Programme and Exhibition Guide | POSTERS AND ELECTRONIC POSTERS

243